Latest & greatest articles for breast cancer

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on breast cancer or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on breast cancer and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for breast cancer

161. Prognostic significance of P-cadherin expression in breast cancer: a meta-analysis

Prognostic significance of P-cadherin expression in breast cancer: a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing

2019 PROSPERO

162. Second-line endocrine treatment in hormone receptor-positive, endocrine-resistant advanced breast cancer: a systemic review and network meta-analyses

Second-line endocrine treatment in hormone receptor-positive, endocrine-resistant advanced breast cancer: a systemic review and network meta-analyses Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith

2019 PROSPERO

163. Predictors of psychological distress in caregivers of women with breast cancer in developing countries: a systematic review protocol

Predictors of psychological distress in caregivers of women with breast cancer in developing countries: a systematic review protocol Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2019 PROSPERO

164. The efficacy and safety of nab-paclitaxel compared with conventional paclitaxel for breast cancer patients: a systemic review and meta-analysis

The efficacy and safety of nab-paclitaxel compared with conventional paclitaxel for breast cancer patients: a systemic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2019 PROSPERO

165. Prognostic models for predicting ovarian function in young breast cancer patients after chemotherapy: a systematic review and meta-analysis

Prognostic models for predicting ovarian function in young breast cancer patients after chemotherapy: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

166. The quality of CONSORT adverse events reporting in phase III randomized controlled trials of breast and colorectal cancers: a systematic review

The quality of CONSORT adverse events reporting in phase III randomized controlled trials of breast and colorectal cancers: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

167. Benefits and harms of breast cancer screening among women with a personal history of breast cancer: a systematic review and meta-analysis

Benefits and harms of breast cancer screening among women with a personal history of breast cancer: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

168. A systematic review of women's experiences of breast or trunk lymphoedema following treatment for breast cancer.

A systematic review of women's experiences of breast or trunk lymphoedema following treatment for breast cancer. Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

169. Fluorescence imaging in breast cancer surgery: a systematic review

Fluorescence imaging in breast cancer surgery: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g

2019 PROSPERO

170. Management of side-effects among women with breast cancer using adjuvant hormonal therapy: a systematic review of reviews

Management of side-effects among women with breast cancer using adjuvant hormonal therapy: a systematic review of reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

171. Hormone receptor expression and molecular sub-types of breast cancer in the sub-Saharan Africa: a systematic review and meta-analysis

Hormone receptor expression and molecular sub-types of breast cancer in the sub-Saharan Africa: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

172. The effect of exercise program on aromatase inhibitor induced by musculoskeletal symptoms in breast cancer survivors: a systematic review and meta-analysis

The effect of exercise program on aromatase inhibitor induced by musculoskeletal symptoms in breast cancer survivors: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

173. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer [Cochrane protocol]

Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

174. The adverse effects of trastuzumab-containing regimes as an adjuvant or neoadjuvant therapy in breast cancer: a piggy-back systematic review and network meta-analysis

The adverse effects of trastuzumab-containing regimes as an adjuvant or neoadjuvant therapy in breast cancer: a piggy-back systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

175. The experience of patients with breast or prostate cancer recurrence: an integrative review

The experience of patients with breast or prostate cancer recurrence: an integrative review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

176. Effect of vitamin D supplementation on risk of breast cancer and breast density: a systematic review and meta-analysis of randomized controlled trials

Effect of vitamin D supplementation on risk of breast cancer and breast density: a systematic review and meta-analysis of randomized controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

177. Results from different aerobic exercise protocol on cardiorespiratory fitness in breast cancer patients under chemotherapy: a systematic review and meta-analysis

Results from different aerobic exercise protocol on cardiorespiratory fitness in breast cancer patients under chemotherapy: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

178. Effects of exercise and wellness programming for women receiving or have received treatment for breast cancer: a systematic review

Effects of exercise and wellness programming for women receiving or have received treatment for breast cancer: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record

2019 PROSPERO

179. Chinese medicine for immunological functions in women with breast cancer or a history of breast cancer [Cochrane protocol]

Chinese medicine for immunological functions in women with breast cancer or a history of breast cancer [Cochrane protocol] Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

180. Breast cancer patients' experiences of mindfulness-based stress reduction (MBSR): a qualitative systematic review

Breast cancer patients' experiences of mindfulness-based stress reduction (MBSR): a qualitative systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO